Using Biosimulation to Develop Pediatric Therapeutics

An Empowered Patient Podcast


Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos of Certara


An Empowered Patient Podcast, hosted by Karen Jagoda


Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company's platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates. They are also operationalizing clinical trials to be more efficient and potentially less invasive which is important when working with young children.

To listen to the podcast: https://empoweredpatientradio.com/using-biosimulation-to-develop-pediatric-therapeutics-with-lynne-georgopoulos-certara


Transcript of the podcast: https://empoweredpatientradio.com/using-biosimulation-to-develop-pediatric-therapeutics-with-lynne-georgopoulos-certara-transcript


Certara website: https://www.certara.com/


Empowered Patient website: https://www.empoweredpatientradio.com

Medical and Pharma Insider website: https://www.medicalandpharmainsider.com


  • LinkedIn Basic Black
  • Twitter Basic Black

FC Global Strategies LLC

Tel. +1 646 450 8909

Email info@fcglobalstrategies.com

Website www.fcglobalstrategies.com

389 Corona Street, Suite 589

Denver CO 80218 USA

 

© 2021 FC Global Strategies LLC